WGA/11/12
Sponsored by Aarnav Khanna, Luke Sanders, John Kukulka, Adwaya Yesare of Ravenwood High School
The delegates above represented the Delegation of Democratic Republic of the Congo.
This legislation was filed in the Social, Humanitarian and Cultural category
Presented as part of the MUN B 2023 conference
1 | To the General Assembly: |
2 | |
3 | Concerned that malaria continues to cause more than one million preventable deaths a year, and |
4 | that over 11% of them are traceable to the Democratic Republic of the Congo, and that 2,000 |
5 | children dying every day from malaria in the DRC; |
6 | |
7 | Deeply concerned that previous efforts to combat malaria in the Democratic Republic of the Congo |
8 | have been made, yet were unsuccessful; |
9 | |
10 | Bearing in mind that 95% of the Congolese live in malaria infested areas, putting them at |
11 | considerable risks; |
12 | |
13 | Stressing the fact that over 300,000 people in the Democratic Republic of the Congo currently |
14 | suffer from malaria; |
15 | |
16 | Emphasizing the fact that the government of the Democratic Republic of the Congo has recognized |
17 | the effects of malaria in the country; |
18 | |
19 | Exemplifying that nearly 50% of the 620,000 deaths of children who die before their fifth birthday |
20 | in the Democratic Republic of the Congo are caused by malaria; |
21 | |
22 | Acknowledging that the period 2001-2010 has been proclaimed the (Decade to Roll Back Malaria in |
23 | Developing Countries, Particularly in Africa) by the United Nations General Assembly, and |
24 | combating HIV/AIDS, malaria, and other diseases is included in the internationally agreed |
25 | development goals, including those contained in the United Nations Millennium Declaration; |
26 | |
27 | Recalling further United Nations General Assembly resolution 59/256 entitled (2001-2010: Decade |
28 | to Roll Back Malaria in Developing Countries, Particularly in Africa); |
29 | |
30 | Calling upon the UN to uphold their promise of vaccinating all citizens of sub-saharan Africa, but |
31 | only 18 million vaccines have been sent out to be distributed among 12 countries in Africa, and the |
32 | DRC has a population of over 90 million, |
33 | |
34 | Noting with grave concern that the above resolution states that malaria, especially in Africa, must |
35 | be treated if we intend on reaching recommendations such as the ones set during the Abuja |
36 | |
37 | Mindful that the global burden of malaria needs to be decreased to reduce child mortality by two- |
38 | thirds by 2027 and to help achieve the other internationally agreed development goals, including |
39 | those contained in the United Nations Millennium Declaration, of improving maternal health and |
40 | eradicating extreme poverty; |
41 | |
42 | Recalling Sustainable Development Goal 3 where the UN pledged to end the epidemic of AIDS, |
43 | Tuberculosis, Malaria, and other neglected tropical diseases by 2030, yet only 12% of the |
44 | population is vaccinated for said diseases; |
45 | |
46 | Stressing even more that 241 million cases of Malaria occurred in 2020, with a new epidemic |
47 | possible if left untreated, and 240 million more cases occur annually, |
48 | |
49 | We, the delegation of the Democratic Republic of the Congo, hereby: |
50 | |
51 | Formally request the United Nations World Health Organization (WHO) Global Malaria Programme |
52 | (GMP) to provide $471.95 million USD to fund vaccinations for every citizen of the Democratic |
53 | Republic of the Congo, along with providing $2.7 million USD to give mosquito nets to citizens, |
54 | allocate $49.7 million USD to establish a malaria research, development, and distribution |
55 | foundational building, along with providing an additional $20.85 million USD annually for the |
56 | spraying of insecticides and providing vaccinations for new generations of children; |
57 | |
58 | Emphasizing the fact that the malaria foundational building listed above will not only provide a |
59 | method of distributing said vaccines, but also provides economic opportunities for citizens |
60 | choosing to work in the facility, while also providing a way for the Democratic Republic of the |
61 | Congo to develop their own vaccines without the help of the United Nations; |
62 | |
63 | Establish national policies and operational plans to ensure that at least 80% of those at risk of, or |
64 | suffering from, malaria benefit from major preventive and curative interventions by 2027 by WHO |
65 | technical recommendations, to ensure a reduction in the burden of malaria; |
66 | |
67 | Assess and respond to the need for integrated human resources at all levels of the Democratic |
68 | Health system to achieve the targets of the Abuja Declaration on Roll Back Malaria in Africa and |
69 | the internationally agreed development goals of the United Nations Millennium Declaration, and to |
70 | take the necessary steps to ensure the recruitment, training and retention of health personnel; |
71 | |
72 | Further enhance financial support and development assistance to malaria activities to achieve the |
73 | above targets and goals, and to encourage and facilitate the development of new tools to increase |
74 | the effectiveness of malaria control; |
75 | |
76 | Pursue a rapid scale-up of prevention by applying expeditious and cost-effective approaches, |
77 | including targeted free, or highly subsidized, distribution of materials and medicines to all citizens |
78 | of the Democratic Republic of the Congo; |
79 | |
80 | Support indoor residual insecticide spraying, where local conditions indicate the need for this |
81 | solution to killing the diseased pests; |
82 | |
83 | Work to coordinate efforts to improve surveillance, monitoring, and evaluation systems so as |
84 | better to track and report changes in the coverage of recommended Roll Back Malaria |
85 | interventions and subsequent reductions in the burden of malaria; |
86 | |
87 | Further promote cooperation and partnership between countries supporting malaria control |
88 | programs in order to ensure that funds available to combat the disease are used efficiently and |
89 | effectively. |
90 |